For years, the medical approach to chest pain has centered on a primary question: is there a blockage in the coronary arteries? When imaging or invasive procedures show “clear” arteries, patients are often told their symptoms are non-cardiac or benign. However, emerging evidence in non-invasive imaging for coronary artery disease is challenging this binary view, revealing that a significant population of patients suffers from heart-related ischemia despite having no obstructive blockages.
This shift in understanding is highlighted in a recent professional exchange regarding the diagnosis of chronic coronary artery disease. The discussion emphasizes the critical importance of identifying two specific conditions: Angina with Non-Obstructive Coronary Arteries (ANOCA) and Ischaemia with No Obstructive Coronary Artery disease (INOCA). These conditions represent a “hidden” burden of cardiovascular disease where the heart muscle does not receive enough oxygen, even though the main epicardial arteries remain open.
The clinical implications are substantial. Data from the Inclusive Invasive Physiological Assessment in Angina Syndromes registry indicates that ANOCA accounted for 20% of patients who were referred for invasive coronary angiography after receiving a positive stress test. This suggests that one in five patients who appear to have “normal” arteries on a standard angiogram are actually experiencing a physiological failure of blood flow to the heart.
Understanding the Gap: ANOCA and INOCA
To the patient, the symptoms of ANOCA and INOCA are indistinguishable from traditional obstructive coronary artery disease: pressure, tightness, or pain in the chest, often triggered by exertion or stress. However, the underlying pathology is different. While traditional heart disease involves the buildup of plaque (atherosclerosis) that narrows the artery, these non-obstructive conditions often involve microvascular dysfunction—where the tiny vessels deeper in the heart muscle fail to dilate properly.
The distinction is not merely academic. Because these patients do not have a “blockage” to fix with a stent or bypass surgery, they are frequently underdiagnosed or mismanaged. This diagnostic gap leads to a diminished quality of life, as patients continue to experience debilitating chest pain while being told their tests are normal. More alarmingly, research indicates that these conditions are not benign; they are associated with an increase in mortality, placing these patients at a higher risk for adverse cardiac events than those with entirely healthy coronary systems.
The Role of Non-Invasive Imaging
The move toward non-invasive imaging is designed to bridge this gap. Traditionally, the “gold standard” for diagnosing coronary issues was the invasive coronary angiogram. While highly accurate for finding blockages, We see less effective at detecting the functional issues characteristic of INOCA. Modern non-invasive tools—such as advanced cardiac MRI, PET scans, and computed tomography angiography (CCTA)—allow clinicians to visualize both the anatomy of the arteries and the actual perfusion of the heart muscle.
By focusing on “ischemia” (lack of blood flow) rather than just “stenosis” (narrowing), doctors can identify patients who need medical therapy for microvascular dysfunction even when their arteries look clear. This shift allows for a more personalized treatment plan, moving away from a one-size-fits-all approach to chest pain.
| Condition | Artery Appearance | Primary Cause | Clinical Impact |
|---|---|---|---|
| Obstructive CAD | Narrowed/Blocked | Atherosclerotic Plaque | Ischemia/Infarction |
| ANOCA | Non-obstructive | Microvascular/Spasm | Chest Pain/Reduced QoL |
| INOCA | Non-obstructive | Impaired Perfusion | Increased Mortality Risk |
Why This Matters for Public Health
The prevalence of these conditions suggests a systemic underestimation of cardiovascular risk in certain populations. Historically, women have been more likely to present with INOCA/ANOCA symptoms than men, leading to a gender gap in cardiac care where women’s chest pain is more frequently dismissed as anxiety or non-cardiac in origin. By validating these conditions through rigorous imaging and registry data, the medical community is moving toward a more equitable standard of care.
The impact of these findings extends to how healthcare systems prioritize testing. If 20% of patients with positive stress tests have non-obstructive disease, the reliance on invasive angiography as the sole diagnostic tool may be insufficient. There is a growing call for “physiological assessment”—testing how the heart actually functions under stress—rather than just looking at the “plumbing” of the arteries.
The Path Forward in Diagnosis
The current trajectory of cardiology emphasizes a multi-modal approach. This means combining anatomical data (what the artery looks like) with functional data (how the blood is actually flowing). The goal is to identify the “invisible” patient—the one whose angiogram is clean but whose heart is starving for oxygen.
For patients, this means a more nuanced conversation with their providers. Instead of asking “Is there a blockage?”, the more pertinent question is becoming “Is my heart getting enough blood during exertion?” This shift in questioning drives the adoption of more sophisticated non-invasive imaging protocols that can detect microvascular dysfunction without the risks associated with invasive catheterization.
Disclaimer: This article is provided for informational purposes only and does not constitute medical advice. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
As clinical guidelines evolve, the next major checkpoint will be the integration of these non-invasive imaging protocols into standard primary care pathways for chest pain, potentially reducing the number of unnecessary invasive procedures while increasing the detection rate for microvascular disease. We will continue to monitor the updates from global cardiology registries as they refine the treatment protocols for ANOCA and INOCA.
Do you have experience with non-obstructive coronary artery disease or questions about cardiac imaging? Share your thoughts in the comments or share this article with others who may find this information helpful.
Worth a look
